Unique ID issued by UMIN | UMIN000047959 |
---|---|
Receipt number | R000054649 |
Scientific Title | A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression. |
Date of disclosure of the study information | 2022/06/06 |
Last modified on | 2022/06/06 11:21:46 |
A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.
A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.
A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.
A retrospective exploratory integrative analysis of the efficacy of postoperative adjuvant chemotherapy for Stage II and III rectal cancer by stage of progression.
Japan |
Rectal cancer
Gastrointestinal surgery |
Malignancy
NO
Postoperative adjuvant chemotherapy for rectal cancer is similar to that for colorectal cancer, but there are very few reports on the effectiveness of postoperative adjuvant chemotherapy for rectal cancer alone. Currently, it is difficult to have a control group for surgery alone in clinical trials of adjuvant chemotherapy. This time, we will integrate four clinical trials including rectal cancer cases of the JFMC data base, utilized the surgery alone group as historical control data, adjusted the background bias using the propensity score, and we will examine the efficacy of postoperative adjuvant chemotherapy for rectal cancer at different stages of progression.
Others
We will integrate four clinical trials including rectal cancer cases of the JFMC data base, utilized the surgery alone group as historical control data, adjusted the background bias using the propensity score, and we will examine the efficacy of postoperative adjuvant chemotherapy for rectal cancer at different stages of progression.
Relapse-free survival
Overall survival
Others,meta-analysis etc
20 | years-old | <= |
80 | years-old | >= |
Male and Female
Of the 4 studies (No.7, 15, 35, 38)conducted by JFMC in the past, registered cases diagnosed with rectal cancer were included in the analysis.
-
3677
1st name | Takaki |
Middle name | |
Last name | Yoshikawa |
Japanese Foundation for Multidisciplinary Treatment of Cancer
Database Project Support Committee
136-0071
Tani Building 3F, 1-28-6 Kameido, Koto-ku, Tokyo
0356277594
jfmc-dc@jfmc.or.jp
1st name | Yukari/Masaru |
Middle name | |
Last name | Kawamura/Mutoh |
Japanese Foundation for Multidisciplinary Treatment of Cancer
Data Management Section/Statistical Analysis Section
136-0071
Tani Building 3F, 1-28-6 Kameido, Koto-ku, Tokyo
0356277594
jfmc-dc@jfmc.or.jp
Japanese Foundation for Multidisciplinary Treatment of Cancer
Japanese Foundation for Multidisciplinary Treatment of Cancer
Non profit foundation
Epidemiological and Clinical research Information Network (ECRIN)
21-7 Shogoin Sannocho Sakyo-ku, Kyoto-shi, Kyoto-fu 606-8392
075-762-1200
naomi.iwahori@ecrin.or.jp
NO
2022 | Year | 06 | Month | 06 | Day |
Unpublished
Preinitiation
2022 | Year | 03 | Month | 25 | Day |
2022 | Year | 03 | Month | 25 | Day |
2022 | Year | 09 | Month | 01 | Day |
2023 | Year | 03 | Month | 31 | Day |
Relapse-free survival
Overall survival
2022 | Year | 06 | Month | 06 | Day |
2022 | Year | 06 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054649